161 related articles for article (PubMed ID: 35935578)
1. Anticancer Effect of Puerarin on Ovarian Cancer Progression Contributes to the Tumor Suppressor Gene Expression and Gut Microbiota Modulation.
Ye Y; Gao Y; Fang Y; Xu L; He F
J Immunol Res; 2022; 2022():4472509. PubMed ID: 35935578
[TBL] [Abstract][Full Text] [Related]
2. Puerarin induces platinum-resistant epithelial ovarian cancer cell apoptosis by targeting SIRT1.
Duan J; Yin M; Shao Y; Zheng J; Nie S
J Int Med Res; 2021 Sep; 49(9):3000605211040762. PubMed ID: 34590923
[TBL] [Abstract][Full Text] [Related]
3. Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer.
Mai Z; Han Y; Liang D; Mai F; Zheng H; Li P; Li Y; Ma C; Chen Y; Li W; Zhang S; Feng Y; Chen X; Wang Y
mSystems; 2024 Jun; ():e0130123. PubMed ID: 38899930
[TBL] [Abstract][Full Text] [Related]
4. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
5. Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity.
Li B; Liu M; Wang Y; Gong S; Yao W; Li W; Gao H; Wei M
Biomed Pharmacother; 2020 Dec; 132():110923. PubMed ID: 33125971
[TBL] [Abstract][Full Text] [Related]
6. Biocatalytical Acyl-Modification of Puerarin: Shape Gut Microbiota Profile and Improve Short Chain Fatty Acids Production in Rats.
Mo L; Zhao GL; Li XF; He N; Xiao XL; Xu HX; Yu YG
Plant Foods Hum Nutr; 2022 Mar; 77(1):44-50. PubMed ID: 34822099
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
8. Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition.
Zhou Y; Xue R; Wang J; Ren H
Braz J Med Biol Res; 2020; 53(4):e8882. PubMed ID: 32294699
[TBL] [Abstract][Full Text] [Related]
9. Puerarin ameliorates depression-like behaviors of with chronic unpredictable mild stress mice by remodeling their gut microbiota.
Song X; Wang W; Ding S; Liu X; Wang Y; Ma H
J Affect Disord; 2021 Jul; 290():353-363. PubMed ID: 34049088
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer.
Feng L; Shen F; Zhou J; Li Y; Jiang R; Chen Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32190895
[TBL] [Abstract][Full Text] [Related]
11. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
Li L; Liu JD; Gao GD; Zhang K; Song YW; Li HB
Cancer Med; 2020 Sep; 9(17):6399-6410. PubMed ID: 32691991
[TBL] [Abstract][Full Text] [Related]
12. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity.
Wang Y; Ma Y; Zheng Y; Song J; Yang X; Bi C; Zhang D; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):728-35. PubMed ID: 23089583
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.
Dai J; Wei R; Zhang P; Kong B
J Transl Med; 2019 Jun; 17(1):190. PubMed ID: 31171023
[TBL] [Abstract][Full Text] [Related]
15. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.
Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L
Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346
[TBL] [Abstract][Full Text] [Related]
16. Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
Anticancer Agents Med Chem; 2017; 17(8):1093-1101. PubMed ID: 28002999
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review.
Giudice E; Salutari V; Ricci C; Nero C; Carbone MV; Ghizzoni V; Musacchio L; Landolfo C; Perri MT; Camarda F; Scambia G; Lorusso D
Crit Rev Oncol Hematol; 2021 Dec; 168():103542. PubMed ID: 34801701
[TBL] [Abstract][Full Text] [Related]
18. Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis.
Hu Y; Li X; Lin L; Liang S; Yan J
Oncol Rep; 2018 Apr; 39(4):1731-1738. PubMed ID: 29393465
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
Guo T; Yuan D; Zhang W; Zhu D; Xiao A; Mao G; Jiang W; Lin M; Wang J
Hum Cell; 2021 Mar; 34(2):579-587. PubMed ID: 33400246
[TBL] [Abstract][Full Text] [Related]
20. Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.
Du L; Zhang L; Sun F
Cancer Biother Radiopharm; 2022 Aug; 37(6):435-450. PubMed ID: 33016781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
